Systemic microbial antigen administration ameliorates experimental autoimmune encephalomyelitis via MHC-II...

Area of Science:

• Neuroimmunology
• Microbial Immunology
• Autoimmunity

Background:

• Microbial stimuli influence central nervous system (CNS) neuroinflammation, but underlying molecular mechanisms remain unclear.
• Understanding how microbial antigens affect CNS autoimmunity is crucial for developing novel therapeutic strategies.

Purpose of the Study:

• To investigate the impact of systemic pre-disease microbial antigen administration on immune responses in a mouse model of CNS autoimmunity.
• To elucidate the molecular mechanisms by which microbial antigens induce immune tolerance in experimental autoimmune encephalomyelitis (EAE).

Main Methods:

• Mice were administered antigens from Helicobacter pylori (Hp) or E. coli, or PBS, via intraperitoneal injections before induction of MOG-induced EAE.
• Evaluated disease incidence and severity, splenocyte proliferation against MOG peptide in vitro, chemokine expression in lymphoid organs and CNS, and microglia/macrophage phenotypes (Iba1, arginase, MHC-II).

Main Results:

• Microbial antigen administration significantly decreased EAE incidence and severity compared to controls.
• Reduced splenocyte proliferation and decreased expression of chemoattractant chemokines in both peripheral and CNS tissues were observed.
• EAE amelioration correlated with increased anti-inflammatory microglia (Iba1+ arginase+) and reduced MHC-II expression on antigen-presenting cells in the CNS.

Conclusions:

• Systemic administration of microbial antigens can induce immune tolerance in the context of CNS autoimmunity.
• Mechanisms may involve modulation of antigen presentation through non-myelin peptide-specific pathways.
• Findings offer insights into potential therapeutic interventions for neuroinflammatory diseases.